Amy Langdon
Impact in
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Clostridium difficile and Clostridium perfringens research 6
-
- Gut microbiota and health 4
- Co-authors
- Gautam Dantas (7 shared papers)Nathan Crook (1 shared paper)Drew J. Schwartz (4 shared papers)Emily J. Fleming (1 shared paper)David Emerson (1 shared paper)Nicole Poulton (1 shared paper)Manuel Martínez‐García (1 shared paper)Ramūnas Stepanauskas (1 shared paper)
- Journals
- Genome Medicine (4 papers)The Medical Journal of Australia (1 paper)The Lancet Microbe (1 paper)PLoS ONE (1 paper)Age and Ageing (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Amy Langdon
13 papers receiving 1.1k citations
Amy Langdon's Hit Papers
Peers
Comparison fields: 5 of 127
- Applied Microbiology and Biotechnology 29
- Infectious Diseases 253
- Molecular Medicine 70
- Biological Psychiatry 31
- Gastroenterology 50
Countries citing papers authored by Amy Langdon
This map shows the geographic impact of Amy Langdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Langdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Langdon more than expected).
Fields of papers citing papers by Amy Langdon
This network shows the impact of papers produced by Amy Langdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Langdon. The network helps show where Amy Langdon may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Langdon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation Hit paper breakdown → | 2016 | 636 |
| 2 | 2020 | 212 | |
| 3 | 2011 | 87 | |
| 4 | 2021 | 62 | |
| 5 | 2013 | 44 | |
| 6 | 2023 | 41 | |
| 7 | 2018 | 15 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 2 | |
| 11 | 2021 | 2 | |
| 12 | 2016 | 2 | |
| 13 | 2025 | 1 |
About Amy Langdon
Amy Langdon is a scholar working on Infectious Diseases, Molecular Biology, Surgery, Gastroenterology and Cardiology and Cardiovascular Medicine, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (6 papers), Gut microbiota and health (4 papers), Cardiovascular Syncope and Autonomic Disorders (3 papers), Gastrointestinal motility and disorders (2 papers), Metal Extraction and Bioleaching (1 paper), Mycobacterium research and diagnosis (1 paper), Child Nutrition and Water Access (1 paper) and Chromosomal and Genetic Variations (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (29 citations), Infectious Diseases (253 citations), Molecular Medicine (70 citations), Biological Psychiatry (31 citations) and Gastroenterology (50 citations). Amy Langdon has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Gautam Dantas, Nathan Crook, Drew J. Schwartz, Emily J. Fleming, David Emerson, Nicole Poulton, Manuel Martínez‐García, Ramūnas Stepanauskas, Carey‐Ann D. Burnham and Kimberly A. Reske. Their work appears in journals such as Genome Medicine, The Medical Journal of Australia, The Lancet Microbe, PLoS ONE and Age and Ageing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.